{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/03/26/3262853/28908/en/Tonix-Pharmaceuticals-Announces-First-Participant-Dosed-in-Phase-1-Investigator-Initiated-Pharmacodynamic-Study-of-TNX-1900-Intranasal-Potentiated-Oxytocin-to-Assess-Potential-for-.html", "message": "News view counter 625187 successfully enlarged"}